Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

IN BRIEF: Omega awaits approval of Visitect under new UK regulations

4th Nov 2021 06:55

Omega Diagnostics Group PLC - Alva, Scotland-based medical diagnostics company - Notes the UK Health Security Agency's medical devices regulations, which were implemented on Monday. The new regulations require all suppliers of Covid-19 tests to submit information for desktop review prior to the end of October if they want their products to remain on sale in the UK after this date. Omega says it has submitted all documentation ahead of the deadlines and paid the necessary fee, but its Visitect professional-use Covid-19 antigen test has yet to be approved.

Current stock price: 46.50 pence

Year-to-date change: down 28%

By Evelina Grecenko; [email protected]

Copyright 2021 Alliance News Limited. All Rights Reserved.


Related Shares:

ODX.L
FTSE 100 Latest
Value8,809.74
Change53.53